Senthil's research aims to understand how immuno-suppressive drugs and cells can interact with mesenchymal stem cells (MSCs).
Immunology and Regenerative Medicine/Glycosylation
Scaffold-Mediated Stem Cell Delivery as an Effective Therapeutic for Critical Limb Ischemia
Mikey's research is in examining the role of modified human endothelial progenitor cells and mesenchynal stem cells in the treatment of cardiovasuclar disease.
The aim of this PhD project is to develop tissue engineering and cell therapy approaches for the treatment of critical size bone defects.
Mesenchymal Stromal Cell Therapy for Acute Lung Injury
Stem Cell Commitment, Chondrogenesis, Transcriptional Networks
Characterisation of novel biomarkers for schizophrenia.
Investigation of immunological and cartilage repair properties of allogeneic differentiated mesenchymal stem cells and articular chondrocytes.
Development of human artificial chromosomes for gene therapy in induced pluripotent stem cells.
Characterization of PBMCs for Chronic Kidney Disease
Tumour-stromal interactions in colon cancer
iPS stem cells, neuroscience
Assessment of vIL-10 as a potential gene target for modulation of the immune environment
Effect of hypoxia on stromal cell ECM to maintain stemness
Cellular and Tissue Engineering Strategies for Bone Regeneration
Cardiovasular, Mesenchymal Stem Cells (MSCs), Angiogenic potential of microencapsulated MSCs
Human MSCs for the treatment of lung ischemia/reperfusion